OBJECTIVE: Largest, single-centre study of clinical and functional outcomes of patients who underwent endoprosthetic replacement (EPR) for aggressive distal tibial bone tumours. METHOD: Retrospective observational study of eight patients was undertaken. RESULTS: Median follow-up was 77 months (range 13-276). Cumulative five and ten year survival was 63% and 42% respectively. Three patients developed either disease recurrence or metastases post-surgery. One patient developed deep infection requiring washout and suppressive antibiotics. No patients required revision surgery. The median MSTS score at last follow up was 66%. CONCLUSIONS: EPR of the distal tibia is a viable option and provides good function outcomes.
OBJECTIVE: Largest, single-centre study of clinical and functional outcomes of patients who underwent endoprosthetic replacement (EPR) for aggressive distal tibial bone tumours. METHOD: Retrospective observational study of eight patients was undertaken. RESULTS: Median follow-up was 77 months (range 13-276). Cumulative five and ten year survival was 63% and 42% respectively. Three patients developed either disease recurrence or metastases post-surgery. One patient developed deep infection requiring washout and suppressive antibiotics. No patients required revision surgery. The median MSTS score at last follow up was 66%. CONCLUSIONS: EPR of the distal tibia is a viable option and provides good function outcomes.
Authors: M Laitinen; J Hardes; H Ahrens; C Gebert; B Leidinger; M Langer; W Winkelmann; G Gosheger Journal: Int Orthop Date: 2005-06-11 Impact factor: 3.075
Authors: S K Shirley; F B Askin; L A Gilula; T J Vietti; P R Thomas; G P Siegal; W R Reinus; J M Kissane; M E Nesbit Journal: J Clin Oncol Date: 1985-05 Impact factor: 44.544